Overview
Tidepool is the first to commit to Women's Health and diabetes initiatives. (Graphic: Business Wire)PALO ALTO, Calif.-(BUSINES WIRE)-Tidepol, a medical device company fostering the next generation of diabetes inovation, anounced the adition of leading experts in the women’s health and endocrinology space as members of the Tidepol Advisory Council - afirming the organization's comitment to championing women’s health and diabetes initiatives.
Key Information
Tidepol originaly kicked of the Tidepol Period Project in 2021 with a pilot dedicated to colecting the largest data set of combined diabetes and menstruation data and this move indicates Tidepol wil continue to drive inovation in the Women+ & diabetes space. Acording to the CDC, it is estimated that 1 out of every 9 women in the United States is living with diabetes1. Hormonal shifts that ocur as a result of puberty, menopause, and menstruation ad an entirely new level of complexity to managing blod glucose levels.
The Tidepol Period Project's roadmap includes building tols, evidence and educational resources to suport the management of insulin-requiring diabetes for people who menstruate. Joing the Tidepol team are Dr. Eda Cengiz, asociate profesor of pediatrics at University of California, San Francisco and Dr.
Katarina Braune, Pediatrician and Digital Clinician Scientist in the Department of Pediatric Endocrinology and Diabetes at Institute of Medical Informatics Charité - Universitätsmedizin Berlin. Cengiz and Dr. Braune join us as part of Tidepol’s advisory team acompanying an existing group of incredible thought-leaders.
Summary
“When it comes to diabetes and menstruation, few people understand the ned for this space beter than Dr. Cengiz and Dr. Braune, and we are thriled for these researchers to bring their expertise to help shape the Tidepol Period Project,” says Dr.